1. Home
  2. HFWA vs ABUS Comparison

HFWA vs ABUS Comparison

Compare HFWA & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heritage Financial Corporation

HFWA

Heritage Financial Corporation

HOLD

Current Price

$25.37

Market Cap

748.4M

Sector

Finance

ML Signal

HOLD

Logo Arbutus Biopharma Corporation

ABUS

Arbutus Biopharma Corporation

HOLD

Current Price

$4.71

Market Cap

848.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HFWA
ABUS
Founded
1927
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
748.4M
848.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HFWA
ABUS
Price
$25.37
$4.71
Analyst Decision
Buy
Strong Buy
Analyst Count
3
2
Target Price
$29.33
$5.00
AVG Volume (30 Days)
187.7K
1.0M
Earning Date
01-22-2026
11-13-2025
Dividend Yield
3.80%
N/A
EPS Growth
53.03
N/A
EPS
1.65
N/A
Revenue
$232,877,000.00
$14,606,000.00
Revenue This Year
$21.61
$125.30
Revenue Next Year
$29.10
N/A
P/E Ratio
$15.29
N/A
Revenue Growth
14.16
116.64
52 Week Low
$19.84
$2.71
52 Week High
$26.58
$5.10

Technical Indicators

Market Signals
Indicator
HFWA
ABUS
Relative Strength Index (RSI) 72.07 61.16
Support Level $24.01 $4.43
Resistance Level $25.53 $4.63
Average True Range (ATR) 0.56 0.19
MACD 0.18 0.04
Stochastic Oscillator 91.46 91.03

Price Performance

Historical Comparison
HFWA
ABUS

About HFWA Heritage Financial Corporation

Heritage Financial Corp is a bank holding company. The company through its subsidiary provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as noninterest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Share on Social Networks: